Mizuho Raises Tesla’s Price Target to $485
Rating
Buy
Price target
$485
Previous
$450
Upside at publication
+10%
Mizuho analyst Vijay Rakesh raised on October 23, 2025, Tesla’s price target to $485 (from $450), while reiterating an ‘Outperform’ rating on the stock.
“TSLA reported in-line 3Q25E Rev/EPS of $28.1B/$0.50 (vs. cons. $26.4B/$0.54).
Main takeaways:
- Auto GM ex-credits at 15.4% (up 40bps q/q) below cons 17.1%, with $0.4B tariff impact, higher avg cost/vehicle, but we see 2026E better with stronger FSD traction and deliveries,
- TSLA focusing on AI5/HW5 with ~40x gains gen/gen, 8x compute and 9x DRAM to 144GB, while ramping Robotaxis/FSD into 2026E-27E, with v14 launched improving safety and Robotaxi learnings,
- Optimus v3 pilots and Cybercab expected 1Q/2Q’26E, though we see ramps farther into 2027E,
- lithium refinery (TX) and LFP lines (NV) exp. to begin production in 4Q’25E and 1Q’26E, respectively, and
- low-cost models launch and FSD1 release in Australia and NZ, with China and Europe FSD premier pending approval.
Maintain Outperform, raise PT to $485, adjust estimates, as we see TSLA well-positioned leading physical AI with Cybercab/FSD traction, humanoid longer term, offset by near-term demand headwinds.”
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.





